Carotid Atherosclerosis Clinical Trial
Official title:
A 2-year, Open-label, Randomized Study to Evaluate the Efficacy of Rosuvastatin Dosing Adjustment by LDL-C Level Compared to That of 5mg Maintenance Dose in Chinese Patients With Carotid Atherosclerotic Plaques
This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.
This will be a 2-year, randomized, open-label, prospective, parallel-group study. It only be held in China-Japan Friendship Hospital. Subjects with Carotid Atherosclerosis Plaques who meet all inclusion and none of the exclusion criteria will be randomized in a 1:1 ratio to receive treatment of rosuvastatin (5 mg, 10mg, 20mg) dosing adjustment by LDL-c level or fixed dose 5 mg. The study will consist of two phases: the Screening/Baseline period(-1to week 0)and the Follow-up period(0 to month 24). The follow-up period will comprise seven visits. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Withdrawn |
NCT03630835 -
99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques
|
Phase 2/Phase 3 | |
Completed |
NCT02722720 -
Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral
|
N/A | |
Completed |
NCT01893489 -
Visualization of Carotid Atherosclerosis by 68Ga-MSA
|
Phase 1 | |
Withdrawn |
NCT00861159 -
RLIP76 in Human Serum in Adults With Rheumatologic Diseases
|
N/A | |
Recruiting |
NCT01743404 -
Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
|
Phase 2 | |
Completed |
NCT00636766 -
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
|
N/A | |
Recruiting |
NCT06166121 -
Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules
|
N/A | |
Withdrawn |
NCT03382249 -
Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques
|
Phase 1/Phase 2 | |
Recruiting |
NCT04679727 -
The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
|
||
Withdrawn |
NCT02995642 -
Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
|
Phase 2 | |
Suspended |
NCT01000181 -
Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT
|
N/A | |
Completed |
NCT00001368 -
Potential Risk Factors for Stroke
|
Phase 1 | |
Recruiting |
NCT04537403 -
PET Detection of CCR2 in Human Atherosclerosis
|
Phase 1 | |
Recruiting |
NCT05800821 -
Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
|
||
Completed |
NCT00147251 -
Stop Atherosclerosis in Native Diabetics Study
|
Phase 4 | |
Completed |
NCT00147797 -
Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy
|
N/A | |
Completed |
NCT00180518 -
ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"
|
Phase 2/Phase 3 | |
Completed |
NCT05230576 -
Intelligent Detection of Carotid Plaque and Its Stability Based on Deep Learning Dynamic Ultrasound Scanning
|
||
Terminated |
NCT03764306 -
New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis
|
N/A |